Guangnong Zhang

Guangnong Zhang

Company: Dicerna TRU of Novo Nordisk

Job title: Associate Director


Panel Discussion: RNAi 2.0; Evaluating RNAi Therapeutics of the Future 10:00 am

This panel discussion will take a look into the future about the hope and promise of RNAi therapeutics. The panel will discuss: Why gene silencing over other RNA therapeutics? What needs to be done for RNAi to become the first line of therapy? What are the pros and cons of gene silencing compared with other…Read more

day: Day One

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.